1. Home
  2. UNCY vs AGAE Comparison

UNCY vs AGAE Comparison

Compare UNCY & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
    SELLHOLDBUYas of 9 hours ago
  • AGAE
    SELLHOLDBUYas of 9 hours ago
  • Stock Information
  • Founded
  • UNCY 2016
  • AGAE 2017
  • Country
  • UNCY United States
  • AGAE United States
  • Employees
  • UNCY N/A
  • AGAE N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • AGAE Cable & Other Pay Television Services
  • Sector
  • UNCY Health Care
  • AGAE Telecommunications
  • Exchange
  • UNCY Nasdaq
  • AGAE Nasdaq
  • Market Cap
  • UNCY 58.7M
  • AGAE 47.2M
  • IPO Year
  • UNCY 2021
  • AGAE N/A
  • Fundamental
  • Price
  • UNCY $0.59
  • AGAE $1.02
  • Analyst Decision
  • UNCY Strong Buy
  • AGAE
  • Analyst Count
  • UNCY 3
  • AGAE 0
  • Target Price
  • UNCY $6.50
  • AGAE N/A
  • AVG Volume (30 Days)
  • UNCY 1.0M
  • AGAE 17.8K
  • Earning Date
  • UNCY 05-12-2025
  • AGAE 05-19-2025
  • Dividend Yield
  • UNCY N/A
  • AGAE N/A
  • EPS Growth
  • UNCY N/A
  • AGAE N/A
  • EPS
  • UNCY N/A
  • AGAE N/A
  • Revenue
  • UNCY N/A
  • AGAE $9,256,023.00
  • Revenue This Year
  • UNCY N/A
  • AGAE N/A
  • Revenue Next Year
  • UNCY $888.72
  • AGAE N/A
  • P/E Ratio
  • UNCY N/A
  • AGAE N/A
  • Revenue Growth
  • UNCY N/A
  • AGAE 36.15
  • 52 Week Low
  • UNCY $0.20
  • AGAE $0.61
  • 52 Week High
  • UNCY $1.60
  • AGAE $1.57
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 49.08
  • AGAE 43.33
  • Support Level
  • UNCY $0.53
  • AGAE $0.92
  • Resistance Level
  • UNCY $0.64
  • AGAE $1.06
  • Average True Range (ATR)
  • UNCY 0.06
  • AGAE 0.05
  • MACD
  • UNCY -0.01
  • AGAE -0.01
  • Stochastic Oscillator
  • UNCY 35.62
  • AGAE 40.00

Stock Price Comparison Chart: UNCY vs AGAE

UNCY
AGAE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0.00.51.01.52.02.53.03.54.04.55.05.56.0UNCY VS AGAE

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use